Associated Papers
Risk prediction for clonal cytopenia: multicenter real-world evidence.
Xie Z et al.
Blood, 2024
38996210 (PubMed )
Supplement: BLOOD_BLD-2024-024756-mmc1.pdf
Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A.
Buscarlet M et al.
Blood, 2018
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.
Kosmider O et al.
Haematologica, 2009
Select a paper to view details